Pitavastatin
CAS NO.:147511-69-1
MF:C25H24FNO4
pKa:4.24±0.10(Predicted)
MF:C25H24FNO4
pKa:4.24±0.10(Predicted)
API051
Quantity
![]()

Pitavastatin is an HMG-CoA reductase inhibitor used to lower lipid levels
and reduce the risk of cardiovascular disease including myocardial infarction and stroke.
![]()
Pitavastatin is indicated for the treatment of adult patients
with primary hyperlipidemia or mixed dyslipidemia to reduce elevated total cholesterol (TC),
low-density lipoprotein cholesterol (LDL-C), apolipoprotein B (Apo B), triglycerides (TG),
and to increase high-density lipoprotein cholesterol (HDL-C).
It is also indicated for the treatment of pediatric patients aged 8 years
and older with heterozygous familial hypercholesterolemia (HeFH) to reduce elevated TC, LDL-C, and Apo B.



